CAS NO 96946-42-8 Atracurium Besylate/Besilate
Strong products of our company. We can supply USP and BP standard with competitive price.
GMP and DMF are available
Indication
For lung cancer, liver cancer and malignant change Hodgkin's lymphoma, disease, reticular cell sarcoma, uterine cancer, leukemia, colon cancer and pancreatic cancer etc all have certain curative effect. Especially for stomach and breast cancer have good effect.
Usage
1. Atracurium is indicated as an adjunct to general anesthesia to produce muscle relaxation during surgical procedures or mechanical ventilation and also to facilitate endotracheal intubation. Atracurium can be used in patients with significant renal or hepatic disease.
2. Adjuncts to Anesthesia, ANALGESIC AND ANESTHETIC DRUGS, Neuromuscular Blockers
Atracurium Besylate CAS 96946-42-8